Hospices Civils de Lyon, a renowned medical organization, is set to lead an innovative clinical trial to assess the efficacy of intensive motor telerehabilitation for stroke recovery. The program will utilize the MindMotion GO device, a medical device designed for remote rehabilitation. This newly announced study, which is not yet recruiting, could bring transformative changes to post-stroke care by leveraging technology to assist motor recovery.
- In this article:
- What changed?
- About the trial
- FAQ
- Implications for professionals
- Disclaimer
- Official announcement
What changed?
The announcement of this trial signals growing momentum in telerehabilitation technologies for stroke patients. MindMotion GO, an advanced motor recovery device, will be the central focus of this program. By combining telemedicine principles and smart device capabilities, the study aims to enable effective rehabilitation from the comfort of a patient’s home. Clinicians, researchers, and regulatory specialists should monitor this development closely as it progresses.
About the trial
Conditions: The trial targets individuals recovering from stroke, aiming to restore motor functionalities and enhance overall outcomes.
Intervention: It revolves around MindMotion GO, a device engineered for telerehabilitation. The device supports precision-controlled motor exercises while providing remote monitoring capabilities to clinicians.
Sponsor: Hosted by Hospices Civils de Lyon, the study exemplifies institutional commitment to addressing gaps in accessible stroke recovery solutions.
Status: As of November 29, 2025, the study has not commenced recruitment, but planning is underway.
Stakeholders in clinical trials, such as health technology developers and regulatory bodies, should anticipate updates as recruitment begins.
FAQ
- What is MindMotion GO? MindMotion GO is a medical device designed for telerehabilitation, focusing on motor recovery after neurological injuries such as stroke.
- Who is eligible for this trial? Exact eligibility criteria are not yet announced; however, it is expected to focus on post-stroke patients seeking motor rehabilitation.
- When will recruitment begin? The trial is currently in a pre-recruitment phase. Updates will follow as details are finalized.
Implications for professionals
The trial introduces opportunities for collaboration between clinical teams, technology developers, and policy experts. Embracing telerehabilitation could significantly expand access to care, enabling scalable interventions beyond traditional inpatient models.
For regulatory teams, this study may establish new data on post-market surveillance and user safety in telerehabilitation, further influencing compliance pathways for similar devices.
Disclaimer
This article is intended for informational purposes and does not constitute legal or regulatory advice. Professionals should consult applicable guidance and regulations directly.
Official announcement
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07254195?term=medical+device